Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomized controlled trial
Susan J Logtenberg, Nanne Kleefstra, Sebastiaan T Houweling, Klaas H Groenier, Reinold O Gans, Henk J Bilo, Susan J Logtenberg, Nanne Kleefstra, Sebastiaan T Houweling, Klaas H Groenier, Reinold O Gans, Henk J Bilo
Abstract
Objective: To investigate the effects of continuous intraperitoneal insulin infusion (CIPII) compared with subcutaneous insulin on health-related quality of life (HRQOL) and treatment satisfaction, and to perform a cost analysis in type 1 diabetes.
Research design and methods: We used an open-label, prospective, crossover, randomized, 16-month study (N = 24). HRQOL and patient satisfaction were assessed with questionnaires (the 36-item short-form health survey [SF-36], the World Health Organization-Five Well-Being Index [WHO-5], and the Diabetes Treatment Satisfaction Questionnaire [DTSQ]). Direct costs of CIPII and continuous subcutaneous insulin infusion (CSII) were compared.
Results: Questionnaire scores were higher with CIPII than with subcutaneous therapy. Yearly direct pump- and procedure-associated costs for CIPII were estimated at 10,910 euroscompared with 4,810 euros for CSII.
Conclusions: Apart from improving glycemic control, CIPII improved HRQOL and treatment satisfaction compared with subcutaneous insulin. Direct pump- and procedure-associated costs are considerably higher for CIPII, however.
Trial registration: ClinicalTrials.gov NCT00286962.
References
- Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, van Ballegooie E, Bilo HJ: Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial. Diabetes Care 2009;32:1372–1377
- Ware J, Snow K, Kosinski M, Gandek B: SF-36 Health Survey: Manual and Interpretation Guide. Boston, The Health Institute, New England Medical Center, 1993.
- Ware JE, Kosinski M, Keller SD: SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, The Health Institute, New England Medical Center, 1994.
- World Health Organization, Regional Office for Europe. Wellbeing measures in primary health care: the Depcare Project. Report on a WHO Meeting, Stockholm, 1998.
- Bech P, Olsen LR, Kjoller M, Rasmussen NK: Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003;12:85–91
- Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W: Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004;78:131–140
- Bradley C: Diabetes treatment satisfaction questionnaire. In Handbook of Psychology and Diabetes. Bradley C: Ed. Chur, Switzerland, Harwood Academic Publishers, 1994, p. 111–132
- Oostenbrink JB, Bouwmans CA, Koopmanschap MA, Rutten FF: Manual for cost: methods and standard costs for economic evaluations in health care. Amstelveen, the Netherlands, Health Care Insurance Board, 2004. [in Dutch]
- Guidance on the use of continuous subcutaneous insulin infusion for diabetes: Technology Appraisal Guidance No. 57. National Institute for Clinical Excellence (NICE), 2003. Available from . Accessed 26 August 2008
- Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N: Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004;8:1–171
- Haveman JW, Logtenberg SJ, Kleefstra N, Groenier KH, Bilo HJ, Blomme AM: Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump. Langenbecks Arch Surg 2010;395:65–71
- Hills M, Armitage P: The two-period cross-over clinical trial. Br J Clin Pharmacol 1979;8:7–20
Source: PubMed